Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2016-09, Vol.51 (9), p.1265-1267
Hauptverfasser:	Dourthe, M E, Ternès, N, Gajda, D, Paci, A, Dufour, C, Benhamou, E, Valteau-Couanet, D
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/67/1059/99 692/700/565/2194 Autografts Bone marrow Busulfan Care and treatment Cell Biology Drug interactions Ewing's sarcoma Hematology Human health and pathology Internal Medicine letter-to-the-editor Life Sciences Medicine Medicine & Public Health Melphalan Methods Neuroblastoma Observations Patient outcomes Public Health Sarcoma Stem cell transplantation Stem Cells Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!